These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2194651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R, Khokhar AR.
    Cancer Res; 1992 Nov 15; 52(22):6341-7. PubMed ID: 1423280
    [Abstract] [Full Text] [Related]

  • 3. Toxicity and anti-tumor activity of hydrophobic diammine and diaminocyclohexane platinum complexes entrapped in multilamellar vesicles.
    Khokhar AR, Al-Baker S, Perez-Soler R.
    Anticancer Drug Des; 1988 Dec 15; 3(3):177-84. PubMed ID: 3207465
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
    Zou Y, Ling YH, Van NT, Priebe W, Perez-Soler R.
    Cancer Res; 1994 Mar 15; 54(6):1479-84. PubMed ID: 8137251
    [Abstract] [Full Text] [Related]

  • 5. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R, Khokhar AR, Lopez-Berestein G.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [Abstract] [Full Text] [Related]

  • 6. Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.
    Perez-Soler R, Priebe W.
    Cancer Chemother Pharmacol; 1992 Dec 15; 30(4):267-71. PubMed ID: 1643693
    [Abstract] [Full Text] [Related]

  • 7. Liposomes as carriers of different new lipophilic antitumour drugs: a preliminary report.
    Sampedro F, Partika J, Santalo P, Molins-Pujol AM, Bonal J, Perez-Soler R.
    J Microencapsul; 1994 Dec 15; 11(3):309-18. PubMed ID: 8064554
    [Abstract] [Full Text] [Related]

  • 8. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M.
    Cancer Res; 1989 Nov 01; 49(21):5969-78. PubMed ID: 2551497
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
    Mayer LD, Tai LC, Ko DS, Masin D, Ginsberg RS, Cullis PR, Bally MB.
    Cancer Res; 1989 Nov 01; 49(21):5922-30. PubMed ID: 2790807
    [Abstract] [Full Text] [Related]

  • 11. [Effectiveness of free and liposomal forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tumors in mice].
    Kaledin VI, Il'nitskaia SI.
    Vopr Onkol; 1996 Nov 01; 42(3):64-6. PubMed ID: 8801744
    [Abstract] [Full Text] [Related]

  • 12. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 13. Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles.
    Perez-Soler R, Yang LY, Drewinko B, Lauterzstain J, Khokhar AR.
    Cancer Res; 1988 Aug 15; 48(16):4509-12. PubMed ID: 3396003
    [Abstract] [Full Text] [Related]

  • 14. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
    Yachi K, Suzuki N, Tanaka N, Okada K, Mitsui I, Kawato Y, Komagata Y, Komiyama K, Kikuchi H.
    Biopharm Drug Dispos; 1996 Nov 15; 17(8):699-715. PubMed ID: 8950048
    [Abstract] [Full Text] [Related]

  • 15. Experimental evaluation of anthracycline analogs.
    Casazza AM.
    Cancer Treat Rep; 1979 May 15; 63(5):835-44. PubMed ID: 455325
    [Abstract] [Full Text] [Related]

  • 16. Toxicity and antitumor activity of cis-bis-cyclopentenecarboxylato-1,2-diaminocyclohexane platinum(II) encapsulated in multilamellar vesicles.
    Perez-Soler R, Khokhar AR, Hacker MP, Lopez-Berestein G.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6269-73. PubMed ID: 3779646
    [Abstract] [Full Text] [Related]

  • 17. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan 15; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 18. Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.
    Zou Y, Priebe W, Stephens LC, Perez-Soler R.
    Clin Cancer Res; 1995 Nov 15; 1(11):1369-74. PubMed ID: 9815933
    [Abstract] [Full Text] [Related]

  • 19. Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum (II) complexes entrapped in liposomes.
    Khokhar AR, al-Baker S, Perez-Soler R.
    Anticancer Drugs; 1992 Apr 15; 3(2):95-100. PubMed ID: 1525398
    [Abstract] [Full Text] [Related]

  • 20. Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes.
    Khokhar AR, al-Baker S, Krakoff IH, Perez-Soler R.
    Cancer Chemother Pharmacol; 1989 Apr 15; 23(4):219-24. PubMed ID: 2647311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.